Table 2.
Compound structure | Use | Computational method | References |
---|---|---|---|
Antimycobacterial agents | Virtual Screening | [89] | |
SENP2 inhibitors | Virtual screening, Molecular Docking | [85] | |
TASK-3 channel antagonist | Pharmacophore based virtual screening | [90] | |
GAPGH inhibitor | Combinatorial docking | [91] | |
Aldose reductase inhibitor | LBVS | [92] | |
Ca2+ antagonist | Pharmacophore searching | [93] | |
Kv1.5 channel blocker | Fragment based, de novo design | [76] | |
Thrombin inhibitor | Combinatorial docking, de novo design | [94] | |
Antiretroviral agent | Virtual Screening | [95] |